Arkade Developers files draft papers for Rs 430-crore IPO
The IPO will only be a fresh issue of shares. The company will use the proceeds for ongoing projects and also to buy land
Source: moneycontrol.com
Stay updated with breaking news from Latest Subscription Figures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The IPO will only be a fresh issue of shares. The company will use the proceeds for ongoing projects and also to buy land
Concord Biotech | The stock performance was much higher than analysts' expectations as well as grey market premium which was around 15 percent over the issue price.